Pacira’s (PCRX) Q3 Earnings Beat Estimates, Revenues Miss Mark Posted byZacks Equity Research November 3, 2021 Leave a comment on Pacira’s (PCRX) Q3 Earnings Beat Estimates, Revenues Miss Mark Pacira’s (PCRX) earnings beat estimates in the third quarter of 2021 while revenues miss the same. Its flagship product Exparel’s sales rise year over year.